APA (7th ed.) Citation

SD, T., HA, M., MIK, H., M, O., Y, S., & B, S. (2025). The Emerging Role of Phosphodiesterase Inhibitors in Fragile X Syndrome and Autism Spectrum Disorder. Pharmaceuticals (Basel, Switzerland), 18(10), . https://doi.org/10.3390/ph18101507

Chicago Style (17th ed.) Citation

SD, Thomas, Mohammed HA, Hamad MIK, Oz M, Statsenko Y, and Sadek B. "The Emerging Role of Phosphodiesterase Inhibitors in Fragile X Syndrome and Autism Spectrum Disorder." Pharmaceuticals (Basel, Switzerland) 18, no. 10 (2025). https://doi.org/10.3390/ph18101507.

MLA (9th ed.) Citation

SD, Thomas, et al. "The Emerging Role of Phosphodiesterase Inhibitors in Fragile X Syndrome and Autism Spectrum Disorder." Pharmaceuticals (Basel, Switzerland), vol. 18, no. 10, 2025, https://doi.org/10.3390/ph18101507.